Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
24 clinical trials · Condition
◉ Watch Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
| Record | Firm | Date |
|---|---|---|
| The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC (NCT03899467) | Suzhou Kintor Pharmaceutical Inc, | 2019-05-30 |
| ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer (NCT03903835) | Karolinska Institutet | 2019-02-01 |
Track Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) automatically
Every clearance here is in the API, with alerts when new ones post.